DENTAL ARTICLE WITH A COATING COMPRISING NANOSTRUCTURES MADE OF YTTRIA-STABILIZED ZIRCONIA
20210236246 · 2021-08-05
Assignee
- Straumann Holding Ag (Basel, CH)
- Fraunhofer Gesellschaft zur Förderung der angewandten Forschung e.V. (München, DE)
Inventors
Cpc classification
A61C8/0012
HUMAN NECESSITIES
C23C14/088
CHEMISTRY; METALLURGY
A61L2400/18
HUMAN NECESSITIES
C04B41/53
CHEMISTRY; METALLURGY
C04B41/5353
CHEMISTRY; METALLURGY
C04B41/455
CHEMISTRY; METALLURGY
A61C2008/0046
HUMAN NECESSITIES
C04B41/53
CHEMISTRY; METALLURGY
C04B41/455
CHEMISTRY; METALLURGY
C04B35/48
CHEMISTRY; METALLURGY
C04B41/5042
CHEMISTRY; METALLURGY
C04B35/48
CHEMISTRY; METALLURGY
A61L27/306
HUMAN NECESSITIES
C04B41/5353
CHEMISTRY; METALLURGY
A61C13/0022
HUMAN NECESSITIES
C04B41/5042
CHEMISTRY; METALLURGY
A61L27/50
HUMAN NECESSITIES
International classification
A61C8/00
HUMAN NECESSITIES
Abstract
A dental article including a dental article body made of a ceramic material and a coating formed on the surface of said dental article body. The coating includes crystalline nanostructures made of yttria-stabilized zirconia YSZ.sub.1, the crystal habitus of at least a portion of the nanostructures having at least approximately the shape of a regular convex polyhedron.
Claims
1. A dental article comprising a dental article body made of a ceramic material and a coating formed on the surface of the dental article body, wherein the coating comprises crystalline nanostructures made of yttria-stabilized zirconia YSZ.sub.1, the crystal habitus of at least a portion of the nanostructures having at least approximately the shape of a regular convex polyhedron.
2. The dental article according to claim 1, wherein the crystal habitus of at least a portion of the nanostructures has at least approximately the shape of a tetrahedron or an octahedron.
3. The dental article according to claim 1, wherein the nanostructures have a cubic, cubic-like or tetragonal crystallographic structure, and in particular are of an intermediate phase between a tetragonal and a cubic phase.
4. The dental article according to claim 1, wherein the amount of yttria in the yttria-stabilized zirconia YSZ.sub.1 is higher than 3 mol-%.
5. The dental article according to claim 1, wherein the amount of yttria in the yttria-stabilized zirconia YSZ.sub.1 is lower than 12 mol-%.
6. The dental article according to claim 1, wherein the amount of yttria in the yttria-stabilized zirconia YSZ.sub.1 is in a range from 6 to 8 mol-%.
7. The dental article according to claim 1, wherein the coating essentially consists of crystalline nanostructures.
8. The dental article according to claim 1, wherein the nanostructures have a size of less than 200 nm.
9. The dental article according to claim 1, wherein the dental article body is made of zirconia.
10. The dental article according to claim 9, wherein the percentage of yttrium in the yttria-stabilized zirconia YSZ.sub.1 differs from the percentage of yttrium in the yttria-stabilized zirconia YSZ.sub.2.
11. The dental article according to claim 1, wherein the surface of the dental article body, on which the coating is formed, is rough.
12. The dental article according to claim 1, wherein the coating has a thickness of about 100 nm at most.
13. A Process for providing a dental article, in particular a dental article according to claim 1, comprising the steps of a. providing a dental article body made of ceramic material, and b. forming on the surface of the dental article body a coating comprising crystalline nanostructures made of yttria-stabilized zirconia YSZ.sub.1 by physical vapor deposition using a target made of a zirconium-yttrium alloy or using a target made of zirconium and a target made of yttrium.
14. The process according to claim 13, wherein the coating is formed by sputter deposition.
15. The process according to claim 13, wherein an oxygen containing gas is used for the physical vapor deposition, a gas containing between about 0.5 to 2 vol-% oxygen.
16. The process according to claim 13, wherein the physical vapor deposition is performed at a temperature above room temperature.
17. The process according to claim 13, wherein prior to the physical vapor deposition, the surface of the basic body is roughened.
18. The process according to claim 17, wherein the process comprising the step of forming a microscale roughness prior to step b, the microscale roughness being defined by at least one of surface parameters S.sub.a, S.sub.t and S.sub.sk: i. S.sub.a being the arithmetic mean deviation of the surface in three dimensions and being in the range from 0.1 μm to 2.0 μm ii. S.sub.t being the maximum peak to valley height of the profile in three dimensions and being in the range from 0.5 μm to 20.0 μm; and/or iii. S.sub.sk being the skewness of the profile in three dimensions and being in the range from −0.01 to −0.6, and that by the coating formed in step at least one of S.sub.a, S.sub.t and S.sub.sk is changed by less than 50% at most and is kept essentially unchanged.
19. The method of applying the dental article according to claim 1 as an implant, in particular a dental implant.
Description
[0113] Images of the respective surfaces are shown in the attached figures of which
[0114]
[0115]
[0116]
[0117]
[0118]
[0119]
[0120] As in particular shown in
[0121] As shown in
[0122] As also shown in
[0123] The biological activity of ZLA and ZLA masking samples has been assessed by a-biological pull-off tests (“a-bio”) using a dental plastic (Exakto-Form Modellkunststoff, bredent GmbH & Co. KG). Specifically, sample disks of a diameter of 15 mm and a height of 1 mm or 1.5 mm were analysed for their pull-off force at a pull-off speed of 0.83 mm/s. These a-bio pull-off forces were compared to the respective pull-off force determined for the sample in vivo.
[0124] The results are shown in Table 5.
TABLE-US-00005 TABLE 5 Pull-off tests (a-biological and in vivo) ZLA ZLA Masking a-bio in vivo a-bio in vivo Average (N) 179 30 171 45 STD (N) 107 13 83 16 a-bio/in 6 4 vivo
[0125] According to Table 5, the ZLA Masking sample showed a markedly higher pull-off force in vivo compared to the ZLA sample. Dividing the pull-off force (a-bio) by the pull-off force (in vivo) results for the ZLA Masking sample in a relatively small value of less than 4. Since a small value is indicative of a high biological activity, the results indicate that the process of the present invention leads to an improved biological activity (compared to the untreated sample for which the above division results in a much higher value of about 6).